The case group had a higher likelihood of a history of autoimmune disease and thyroid disease, as well as a significantly higher percentage of individuals testing positive for ANA and anti-TPO antibodies (13 and 37%, respectively) compared to the control group (5% for ANA and 23% for anti-TPO). This evidence concerns the gene BTG3 and thyroid gland disorder.